Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Evolutionary trajectories of small cell lung cancer under therapy.
Nature. 2024 Mar;627(8005):880-889. doi: 10.1038/s41586-024-07177-7. Epub 2024 Mar 13.
Nature. 2024.
PMID: 38480884
Free PMC article.
Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib.
Werner JM, Wollring MM, Tscherpel C, Rosen EK, Werr L, Stetter I, Rueß D, Ruge MI, Brunn A, Al Shughri A, Kabbasch C, Fink GR, Langen KJ, Galldiks N.
Werner JM, et al. Among authors: werr l.
Neuro Oncol. 2023 Jun 2;25(6):1193-1195. doi: 10.1093/neuonc/noad051.
Neuro Oncol. 2023.
PMID: 36960770
Free PMC article.
No abstract available.
Item in Clipboard
Reliable assessment of telomere maintenance mechanisms in neuroblastoma.
Meeser A, Bartenhagen C, Werr L, Hellmann AM, Kahlert Y, Hemstedt N, Nürnberg P, Altmüller J, Ackermann S, Hero B, Simon T, Peifer M, Fischer M, Rosswog C.
Meeser A, et al. Among authors: werr l.
Cell Biosci. 2022 Sep 24;12(1):160. doi: 10.1186/s13578-022-00896-2.
Cell Biosci. 2022.
PMID: 36153564
Free PMC article.
Item in Clipboard
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models.
Fischer-Mertens J, Otte F, Roderwieser A, Rosswog C, Kahlert Y, Werr L, Hellmann AM, Berding M, Chiu B, Bartenhagen C, Fischer M.
Fischer-Mertens J, et al. Among authors: werr l.
Cell Oncol (Dordr). 2022 Oct;45(5):991-1003. doi: 10.1007/s13402-022-00702-8. Epub 2022 Aug 12.
Cell Oncol (Dordr). 2022.
PMID: 35953764
Free PMC article.
Item in Clipboard
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.
Lategahn J, Tumbrink HL, Schultz-Fademrecht C, Heimsoeth A, Werr L, Niggenaber J, Keul M, Parmaksiz F, Baumann M, Menninger S, Zent E, Landel I, Weisner J, Jeyakumar K, Heyden L, Russ N, Müller F, Lorenz C, Brägelmann J, Spille I, Grabe T, Müller MP, Heuckmann JM, Klebl BM, Nussbaumer P, Sos ML, Rauh D.
Lategahn J, et al. Among authors: werr l.
J Med Chem. 2022 May 12;65(9):6643-6655. doi: 10.1021/acs.jmedchem.1c02080. Epub 2022 Apr 29.
J Med Chem. 2022.
PMID: 35486541
Item in Clipboard
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization.
Werr L, Plenker D, Dammert MA, Lorenz C, Brägelmann J, Tumbrink HL, Klein S, Schmitt A, Büttner R, Persigehl T, Shokat KM, Wunderlich FT, Schram AM, Peifer M, Sos ML, Reinhardt HC, Thomas RK.
Werr L, et al.
Mol Cancer Ther. 2022 May 4;21(5):821-830. doi: 10.1158/1535-7163.MCT-21-0820.
Mol Cancer Ther. 2022.
PMID: 35247925
Free PMC article.
Item in Clipboard
Cite
Cite